Fed 4th Cir. Applies Rigid Pleading Standard in Off-Label Marketing False Claims Act Case
Posted on Health Care Law News January 23, 2013 by author
The Federal Fourth Circuit Court of Appeals dismissed an off-label marketing False Claims Act case based upon the lack of identification in the complaint of specific false claims presented to the government. In U.S. ex rel. Nathan v. Takeda Pharmaceuticals North America, Inc., No.11–2077 (4th Cir. January 11, 2013), the court brushed aside the other Read more →